Meriwether Wealth & Planning’s Collegium Pharmaceutical COLL Stock Holding History

Meriwether Wealth & Planning’s Portfolio COLL Stock Details COLL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$58.4K	Buy	+2,675	New	+$78.1K	0.03%	248

Other funds holding COLL

Artemis Investment Management Edinburgh, United Kingdom $11.5B AUM 61.77% 1-Year Est. Return

Y-Intercept (HK) Hong Kong $4.52B AUM 6.6% 1-Year Est. Return

Eastern Bank Boston, Massachusetts $6.58B AUM 23.57% 1-Year Est. Return

SummerHaven Investment Management Stamford, Connecticut $179M AUM 57.61% 1-Year Est. Return

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

Louisiana State Employees Retirement System Baton Rouge, Louisiana $6.56B AUM 41.43% 1-Year Est. Return

State of Alaska Department of Revenue Juneau, Alaska $9.6B AUM 34.67% 1-Year Est. Return

AssetMark Inc Concord, California $59.5B AUM 15.92% 1-Year Est. Return

Nisa Investment Advisors St. Louis, Missouri $34.7B AUM 25.93% 1-Year Est. Return

Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return

Meriwether Wealth & Planning's COLL Position: Q3 2026 in Review

Meriwether Wealth & Planning opened a new position in Collegium Pharmaceutical (COLL) in Q3 2026: 2,675 shares worth $58.4K. The stake represents 0.03% of the portfolio and ranks #248 among its holdings.

20 funds tracked by Wall St. Rank hold COLL as of Q3 2026.

Meriwether Wealth & Planning held 2,675 shares of Collegium Pharmaceutical worth $58.4K as of Q3 2026.
Collegium Pharmaceutical was a new Meriwether Wealth & Planning position in Q3 2026.
Collegium Pharmaceutical made up 0.03% of Meriwether Wealth & Planning's portfolio in Q3 2026, its #248 holding.
20 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q3 2026.

Based on Meriwether Wealth & Planning's 13F filing for Q3 2026, filed 13 Oct 2026.